HOME DM-BAT:针对低收入老年2型糖尿病患者的家庭糖尿病改良行为激活治疗——随机对照试验研究方案
该研究为一项为期5年的前瞻性随机对照试验,计划纳入200名65岁及以上、HbA1c≥8%的低收入少数族裔2型糖尿病老年患者,随机分为家庭护士电话糖尿病教育与行为激活干预组或常规照护组,随访12个月评估血糖、血压和低密度脂蛋白胆固醇控制效果。
要点
- 研究对象为65岁及以上、HbA1c≥8%的低收入少数族裔2型糖尿病老年患者。
- 干预组接受家庭护士电话糖尿病教育与行为激活,对照组接受家庭护士电话健康教育/支持治疗。
- 主要假设为干预组在12个月随访时临床结局改善显著优于常规照护组。
核心结论
- 研究结果将为家庭糖尿病改良行为激活治疗对低收入少数族裔老年 uncontrolled 2型糖尿病患者的有效性提供重要见解,并为改善少数族裔老年2型糖尿病患者血糖控制和减少糖尿病并发症的策略提供信息。
研究设计与样本
- 为期5年的前瞻性随机对照试验,计划纳入200名65岁及以上、HbA1c≥8%的低收入少数族裔2型糖尿病老年患者。
- 随机分为两组:干预组接受家庭护士电话糖尿病教育与行为激活;常规照护组接受家庭护士电话健康教育/支持治疗。
- 随访12个月,评估干预对血糖控制、血压和低密度脂蛋白胆固醇的效果。
- 试验注册号:ClinicalTrials.gov NCT04203147,于2019年12月18日在美国国立卫生研究院临床试验注册库注册。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: About 13% of African Americans and 13% of Hispanics have diabetes, compared to 8% of non-Hispanic Whites (NHWs). This is more pronounced in the elderly where about 25-30% of those aged 65 and older have diabetes. Studies have found associations between social determinants of health (SDoH) and increased incidence, prevalence, and burden of diabetes; however, few interventions have accounted for the context in which the elderly live by addressing SDoH. Specifically, psychosocial factors (such as cognitive dysfunction, functional impairment, and social isolation) impacting this population may be under-addressed due to numerous medical concerns addressed during the clinical visit. The long-term goal of the project is to identify strategies to improve glycemic control and reduce diabetes complications and mortality in African Americans and Hispanics/Latinos with type 2 diabetes. METHODS: This is a 5-year prospective, randomized clinical trial, which will test the effectiveness of a home-based diabetes-modified behavioral activation treatment for low-income, minority seniors with type 2 diabetes mellitus (T2DM) (HOME DM-BAT). Two hundred, aged 65 and older and with an HbA1c ≥8%, will be randomized into one of two groups: (1) an intervention using in-home, nurse telephone-delivered diabetes education, and behavioral activation or (2) a usual care group using in-home, nurse telephone-delivered, health education/supportive therapy. Participants will be followed for 12 months to ascertain the effect of the intervention on glycemic control, blood pressure, and low-density lipoprotein (LDL) cholesterol. The primary hypothesis is low-income, minority seniors with poorly controlled type 2 diabetes randomized to HOME DM-BAT will have significantly greater improvements in clinical outcomes at 12 months of follow-up compared to usual care. DISCUSSION: Results from this study will provide important insight into the effectiveness of a home-based diabetes-modified behavioral activation treatment for low-income, minority seniors with uncontrolled type 2 diabetes mellitus and inform strategies to improve glycemic control and reduce diabetes complications in minority elderly with T2DM. TRIAL REGISTRATION: ClinicalTrials.gov NCT04203147 ). Registered on December 18, 2019, with the National Institutes of Health Clinical Trials Registry.
引用
- Egede LE, Davidson TM, Knapp RG, et al. HOME DM-BAT: home-based diabetes-modified behavioral activation treatment for low-income seniors with type 2 diabetes-study protocol for a randomized controlled trial. Trials. 2021. PMID: 34749788. doi:10.1186/s13063-021-05744-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。